Cacti Asset Management’s Pfizer PFE Stock Holding History

Cacti Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Hold	69,850	–	–	0.08%	45
2026 Q1	$1.96M	Hold	69,850	–	–	0.12%	44
2025 Q4	$1.75M	Hold	69,850	–	–	0.11%	43
2025 Q3	$1.66M	Hold	69,850	–	–	0.11%	43
2025 Q2	$1.69M	Hold	69,850	–	–	0.12%	45
2025 Q1	$1.76M	Hold	69,850	–	–	0.14%	44
2024 Q4	$1.85M	Hold	69,850	–	–	0.14%	43
2024 Q3	$2.06M	Hold	69,850	–	–	0.15%	42
2024 Q2	$1.94M	Hold	69,850	–	–	0.15%	41
2024 Q1	$2.02M	Hold	69,850	–	–	0.16%	40
2023 Q4	$2M	Hold	69,850	–	–	0.17%	37
2023 Q3	$2.31M	Hold	69,850	–	–	0.21%	34
2023 Q2	$2.56M	Hold	69,850	–	–	0.23%	32
2023 Q1	$2.85M	Hold	69,850	–	–	0.26%	29
2022 Q4	$3.58M	Hold	69,850	–	–	0.33%	27
2022 Q3	$3.06M	Hold	69,850	–	–	0.31%	28
2022 Q2	$3.66M	Hold	69,850	–	–	0.34%	28
2022 Q1	$3.65M	Hold	69,850	–	–	0.28%	29
2021 Q4	$4.13M	Hold	69,850	–	–	0.32%	29
2021 Q3	$3M	Hold	69,850	–	–	0.25%	33
2021 Q2	$2.72M	Hold	69,850	–	–	0.22%	34
2021 Q1	$2.53M	Hold	69,850	–	–	0.22%	34
2020 Q4	$2.57M	Sell	69,850 -3,772	-5%	-$138K	0.25%	33
2020 Q3	$2.54M	Hold	73,622	–	–	0.29%	30
2020 Q2	$2.33M	Buy	73,622 +1,581	+2%	+$53.7K	0.27%	31
2020 Q1	$2.23M	Hold	72,041	–	–	0.26%	28
2019 Q4	$2.69M	Hold	72,041	–	–	0.2%	31
2019 Q3	$2.51M	Hold	72,041	–	–	0.19%	30
2019 Q2	$2.97M	Hold	72,041	–	–	0.23%	32
2019 Q1	$2.9M	Hold	72,041	–	–	0.23%	32
2018 Q4	$2.98M	Hold	72,041	–	–	0.26%	33
2018 Q3	$3M	Hold	72,041	–	–	0.22%	33
2018 Q2	$2.48M	Hold	72,041	–	–	0.2%	33
2018 Q1	$2.41M	Hold	72,041	–	–	0.2%	34
2017 Q4	$2.48M	Hold	72,041	–	–	0.2%	36
2017 Q3	$2.42M	Hold	72,041	–	–	0.21%	35
2017 Q2	$2.3M	Sell	72,041 -7,114	-9%	-$224K	0.21%	38
2017 Q1	$2.58M	Hold	79,155	–	–	0.23%	36
2016 Q4	$2.44M	Hold	79,155	–	–	0.23%	36
2016 Q3	$2.54M	Sell	79,155 -185	-0.2%	-$6.19K	0.26%	36
2016 Q2	$2.65M	Hold	79,340	–	–	0.28%	36
2016 Q1	$2.26M	Hold	79,340	–	–	0.24%	37
2015 Q4	$2.43M	Hold	79,340	–	–	0.26%	37
2015 Q3	$2.36M	Hold	79,340	–	–	0.27%	37
2015 Q2	$2.52M	Buy	79,340 +843	+1%	+$27.5K	0.27%	37
2015 Q1	$2.59M	Buy	78,497 +844	+1%	+$26.8K	0.27%	36
2014 Q4	$2.29M	Sell	77,653 -1,054	-1%	-$30.2K	0.26%	36
2014 Q3	$2.21M	Hold	78,707	–	–	0.27%	36
2014 Q2	$2.22M	Hold	78,707	–	–	0.27%	38
2014 Q1	$2.4M	Hold	78,707	–	–	0.33%	35
2013 Q4	$2.29M	Hold	78,707	–	–	0.34%	34
2013 Q3	$2.15M	Sell	78,707 -1,054	-1%	-$28.7K	0.37%	33
2013 Q2	$2.12M	Buy	+79,761	New	+$2.2M	0.4%	33

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cacti Asset Management's PFE Position: Q2 2026 in Review

Cacti Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 69,850 shares worth $1.68M. The position accounts for 0.08% of the portfolio, ranked #45.

Cacti Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.13M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cacti Asset Management held 69,850 shares of Pfizer worth $1.68M as of Q2 2026.
Cacti Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.08% of Cacti Asset Management's portfolio in Q2 2026, its #45 holding.
Cacti Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Cacti Asset Management's Pfizer position peaked at $4.13M in Q4 2021.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cacti Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.